Ifunanya Nwangene was 26, a Voice Nigeria contestant preparing for her first solo concert. On an ordinary day in her Abuja apartment, a snake bite should not have been fatal. But when she arrived at the first hospital, there was no antivenom. When she reached the Federal Medical Centre, the supply had run out. By the time a friend found medication at a nearby pharmacy, it was too late.
Nwangene's death in 2023 crystallized a crisis that kills roughly 138,000 people globally each year—and leaves another 400,000 with permanent disability. The World Health Organization classifies snakebite envenoming as a neglected tropical disease, which is another way of saying: we know how to prevent these deaths, we're just not doing it consistently enough.
The Gap Between Prevention and Practice
Antivenom exists. It works. But access remains fragmented across Africa, Asia, and South America. A survey of healthcare workers in Brazil, Nigeria, India, and Indonesia found that 99% reported serious obstacles to treatment. More than a third said they faced daily antivenom shortages. Many reported inadequate training on recognizing snakebite progression, poor equipment, and infrastructure that simply can't support rapid response.
We're a new kind of news feed.
Regular news is designed to drain you. We're a non-profit built to restore you. Every story we publish is scored for impact, progress, and hope.
Start Your News DetoxIn Nwangene's case, the delay was measured in hours. In rural areas where snakebites are more common, the delay can be days—by which point the venom has already caused irreversible damage to nerves, blood vessels, and muscle tissue.
The Federal Medical Centre in Abuja disputed claims of shortages, stating staff provided appropriate treatment. But the broader pattern is undeniable. Snakebite treatment sits at the intersection of three problems: insufficient funding, weak supply chains, and low political priority. A disease that kills more people than some cancers receives a fraction of the research investment.
Elhadj As Sy, co-chair of the Global Snakebite Taskforce, put it plainly: "Snakebite must no longer be overlooked or underfunded by the international community. It is time for action—not sympathy, not statements, but action worthy of the scale of this crisis."
The UN set a target to halve snakebite deaths and disabilities by 2030. Campaigners say current funding falls far short of what's needed to reach it. But the mechanics of change are clear: better stockpiling systems, training for healthcare workers, and investment in antivenom production. These aren't mysteries. They're choices.
